Harmful Product Group Action Case Studies
Hugh James case studies
Seroxat
Seroxat is the trade name for paroxetine a member of a
chemically related family of compounds known as Selective Serotonin
Reuptake Inhibitors (SSRIs) the most familiar of which is
fluoxetine (Prozac).
Seroxat is manufactured by
GlaxoSmithKline. Hugh James has been granted a Group Litigation
Order to lead claims on behalf of several hundred people who allege
withdrawal reactions through their use of the drug.
Please see our dedicated Seroxat page for further
details.
If you require more information
about Seroxat, please contact Mark Harvey
Cataract Lenses
In 2005 Hugh James negotiated a settlement protocol which
avoided litigation, on behalf of the victims of a defective
intraocular replacement lens.
The protocol involved check-ups and
remedial treatment for the victims, payment of their expenses and
compensation for the distress and inconvenience caused, with the
result that expensive and lengthy litigation was avoided whilst
providing a real remedy over and above the payment of
compensation.
If you feel you have suffered as a
result of cataract lenses or require more information please
contact Mark
Harvey
Charite Replacement Lumbar Discs
Hugh James is in discussion with New Jersey law firm Bagolie
Friedman and Illinois firm Foote, Meyers, Mielke and Flowers
regarding problems experienced by recipients of the Charite
Artificial Lumbar Disc. The firms have created the international
Charite Artificial Disc Practice Group in response to the serious
problems encountered by these patients.
Court proceedings were issued by
Hugh James on behalf of a woman from Northern England who was
fitted with the Charite Artificial Lumbar disc and who has been
told that it is damaged. She is now back in her pre-operation
state.
Please see our charite replacement lumbar discs information
page.
If you require further information
on replacement lumbar discs contact Mark Harvey
'Quick-fit' knees and hips that can wear out in three
years
"Thousands of patients having hip or knee replacements on
the NHS may find that their new joints do not last more than a few
years."
The Times; 02 September 2008.
A study of joint replacements in England has found that the
latest surgical techniques of hip resurfacing and partial knee
replacement have a lower success rate than the older established
methods where the entire joint is replaced.
The researchers on behalf of The Royal College of Surgeons found
that the newer surgical joints could be twice as likely to fail
than standard ones. Where for example in a total hip replacement
the failure rate is said to be 1 in 111 patients, in the more
modern surgery where one fits a cap over the head of the thigh bone
connecting to a socket rather than a full hip replacement, the
failure rate accelerates to 1 in 38 cases.
DePuy ASR hip replacement implants
have recently been recalled. Hugh James are acting on behalf of
former patients.The recall includes those involved in both
the total hip replacement surgery and hip resurfacing.
If you have concerns that your hip or knee repair has failed
earlier than you were led to believe then you may be entitled to
compensation please contact Mark Harvey for more information.
Related articles
- De Puy hips
recall 07 | 04 | 11
-
Quick-fit’ knee and hip replacements that can wear out in three
years
The Times
02-Sept-08 (read The
Times article)
-
Revision rates after primary hip and knee replacement in
England between 2003 and 2006
PLoS
Medicine Journal 02-Sept 08 (read
PLos Medicine Journal article)
Vinyl chloride exposure linked to fatal liver tumours
Significant evidence has revealed that vinyl
chloride is a carcinogen and linked to angiosarcoma of the liver;
an extremely rare and rapidly fatal tumour.
People who have worked with vinyl
chloride have developed cancers and also developed nerve damage and
immune reactions. Other workers have developed problems with blood
flow in their hands causing the tips of their fingers to become
white and painful particularly when in cold temperatures. In
extreme cases, the bones in the tips of fingers have broken
down.
Millions of pounds in compensation
have already been recovered from workers compensation cases brought
in the UK as well as in the US.
There has been much controversy
about the plastic industry’s knowledge of the risks of vinyl
chloride. Until 1961, the occupational exposure limit was 50
parts per million, this was then reduced to 50 parts per million
but by 1972 the 8 hour exposure limit was reduced to 1 part per
million.
At normal temperatures, vinyl
chloride is a colourless, flammable gas with a mild, sweet
odour. It is a manufactured substance that is used to make
polyvinyl chloride or PVC, which in turn is used to make a variety
of plastic products. Vinyl chloride has been used in
polymerisation and PVC fabrication plants in various parts of the
UK including at ICI and Dow Corning Chemicals.
How we can
help
We are experts in dealing with ill
health and disease claims and our experts can provide specialist
advice in relation to cases involving vinyl chloride exposure.
Please contact Mark Harvey for more information.
Back to top